Aquestive Therapeutics Inc

NASDAQ:AQST   3:59:59 PM EDT
1.14
-0.03 (-2.56%)
Products

Aquestive Therapeutics Receives FDA Fast Track Designation For AQST-109

Published: 03/17/2022 13:37 GMT
Aquestive Therapeutics Inc (AQST) - Aquestive Therapeutics Receives FDA Fast Track Designation for Aqst-109 for Emergency Treatment of Allergic Reactions Including Anaphylaxis.
Aquestive Therapeutics Receives FDA Fast Track Designation for Aqst-109 for Emergency Treatment of Allergic Reactions Including Anaphylaxis.
Aquestive Therapeutics Inc - Expects to Report Topline Results for Full Epiphast Study in First Half of 2022.